Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Kolb, E Anders  [Clear All Filters]
2023
Cooper TM, Alonzo TA, Tasian SK, Kutny MA, Hitzler J, Pollard JA, Aplenc R, Meshinchi S, E Kolb A. Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasms. Pediatr Blood Cancer. 2023:e30584.
Barwe SP, E Kolb A, Gopalakrishnapillai A. Down syndrome and leukemia: An insight into the disease biology and current treatment options. Blood Rev. 2023:101154.
Mark C, Meshinchi S, Joyce B, Gibson B, Harrison C, Bergmann AK, Goemans BF, Pronk CJan H, Lapillonne H, Leverger G, et al. Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias. Br J Haematol. 2023.
2022
Pollard JA, Alonzo TA, Gerbing R, Brown P, Fox E, Choi J, Fisher B, Hirsch B, Kahwash S, Getz K, et al. Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio /ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031. J Clin Oncol. 2022:JCO2101612.
2019
Kazak AE, Swain AMadan, Canter K, Vega G, Joffe N, Deatrick JA, E Kolb A, Chewning J, Pai ALH. A psychosocial clinical care pathway for pediatric hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2019:e27889.
Pai ALH, Swain AMadan, Chen FFang, Hwang W-T, Vega G, Carlson O, Ortiz FArgueta, Canter K, Joffe N, E Kolb A, et al. Screening for family psychosocial risk in pediatric hematopoietic stem cell transplantation with The Psychosocial Assessment Tool (PAT). Biol Blood Marrow Transplant. 2019.